Hepatocellular cystathionine γ lyase/hydrogen sulfide attenuates nonalcoholic fatty liver disease by activating farnesoid X receptor
Wenjing Xu(Jiangnan University), Bin Geng(Chinese Academy of Medical Sciences & Peking Union Medical College), Qinghua Cui(Peking University), Ming‐Hua Zheng(Wenzhou Medical University), Jianglin Fan(Key Laboratory of Guangdong Province), Haizeng Zhang(Chinese Academy of Medical Sciences & Peking Union Medical College), Chunmei Cui(Peking University), Liang‐Jie Tang(Wenzhou Medical University), Christopher D. Byrne(Southampton General Hospital), Yu Han(Wenzhou Medical University), Jun Cai(Beijing Anzhen Hospital), Liming Yang(China Three Gorges Corporation (China)), Zhenzhen Chen(Karolinska Institutet), Guoheng Xu(Southern University of Science and Technology), Giovanni Targher(Ospedale Sacro Cuore Don Calabria), Changting Cui(Chinese Academy of Medical Sciences & Peking Union Medical College)
Cited by 80
Related Papers
The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma
|New England Journal of Medicine|2002|3.9k
NAFLD: A multisystem disease
|Journal of Hepatology|2015|3.1k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Hepatology|2023|2.9k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Journal of Hepatology|2023|2.7k
Prediction of Survival in Follicular Lymphoma Based on Molecular Features of Tumor-Infiltrating Immune Cells
|New England Journal of Medicine|2004|1.4k